Testing quick tests to shorten antibiotics in severe COPD flare
Part of Lungs & breathing clinical trials.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- You have COPD at any severity level.
- You are admitted for a severe COPD flare with breathing worsening that needs ICU care and breathing support (ventilator, noninvasive breathing support, or high-flow oxygen with high oxygen levels).
- You can start ICU care within 3 days of hospital admission.
- You have no clear reason you definitely need antibiotics for an infection outside the lungs (like another infection that requires antibiotics).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a personalized approach to how long antibiotics are given for COPD flare-ups. It aims to see if matching antibiotic duration to each patient's needs is safe and effective, potentially avoiding unnecessary antibiotics.
This trial is testing a new way to choose antibiotics for people with COPD who get pneumonia and need intensive care. The goal is to find the best treatment using a personalized approach.
This trial is looking at patients with a serious worsening of their chronic obstructive pulmonary disease (COPD) who need intensive care. It aims to gather information to help improve treatment for these severe episodes.
This study tests whether a quick test for COVID-19, flu, and RSV can help doctors avoid giving antibiotics when they aren't needed. It's for people with fever or chest infection symptoms who are not sick enough to be hospitalized.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This study tests whether measuring two blood markers (MxA and CRP) can help doctors decide if antibiotics or antiviral drugs are needed for a COPD flare-up. It aims to reduce unnecessary antibiotic use while still treating infections effectively.
Hear when a new Acute Exacerbation of COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.